Get the Stockscreener App
3.26
2.40%
-0.08
After Hours:
3.30
0.04
+1.23%
Sonoma Pharmaceuticals Inc stock is traded at $3.26, with a volume of 19,364.
It is down -2.40% in the last 24 hours and down -17.26% over the past month.
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.
See More
Previous Close:
$3.34
Open:
$3.4549
24h Volume:
19,364
Relative Volume:
0.34
Market Cap:
$5.36M
Revenue:
$14.91M
Net Income/Loss:
$-3.56M
P/E Ratio:
-1.3256
EPS:
-2.4593
Net Cash Flow:
$-1.37M
1W Performance:
-7.91%
1M Performance:
-17.26%
6M Performance:
-0.91%
1Y Performance:
+14.79%
1-Day Range:
$3.26
$3.5683
1-Week Range:
$3.25
$3.65
52-Week Range:
$1.75
$6.9199
Sonoma Pharmaceuticals Inc Stock (SNOA) Company Profile
Name
Sonoma Pharmaceuticals Inc
Sector
Phone
800-759-9305
Address
5445 CONESTOGA COURT, SUITE 150, BOULDER, CA
Compare SNOA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SNOA
Sonoma Pharmaceuticals Inc
|
3.26 | 5.68M | 14.91M | -3.56M | -1.37M | -2.4593 |
|
ZTS
Zoetis Inc
|
115.89 | 51.60B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.06 | 44.51B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.60 | 42.35B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
24.28 | 28.04B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
474.72 | 20.52B | 3.08B | 1.24B | 1.07B | 25.61 |
Sonoma Pharmaceuticals Inc Stock (SNOA) Latest News
Is Sonoma Pharmaceuticals Inc. (O8Z) stock prepared for digital transitionQuarterly Earnings Report & Technical Confirmation Trade Alerts - newser.com
Why Sonoma Pharmaceuticals Inc. (O8Z) stock appears on watchlistsQuarterly Market Summary & Verified Momentum Stock Alerts - newser.com
Is Sonoma Pharmaceuticals Inc. (O8Z) stock attractive post correctionWall Street Watch & Daily Oversold Bounce Ideas - newser.com
How Sonoma Pharmaceuticals Inc. (O8Z) stock stacks up against competitorsInsider Buying & Real-Time Volume Analysis Alerts - newser.com
How to interpret RSI for Sonoma Pharmaceuticals Inc. stockJuly 2025 Macro Moves & Weekly Consistent Profit Watchlists - newser.com
Published on: 2025-11-19 13:22:41 - newser.com
Will Sonoma Pharmaceuticals Inc. (O8Z) stock rise with strong economyQuarterly Portfolio Review & Free High Return Stock Watch Alerts - newser.com
What downside risks could hit Sonoma Pharmaceuticals Inc. (O8Z) stockJuly 2025 Analyst Calls & Long-Term Growth Stock Strategies - newser.com
Sonoma Pharmaceuticals Inc. stock volume spike explainedJuly 2025 Movers & Accurate Intraday Trading Signals - newser.com
What does recent volatility data suggest for Sonoma Pharmaceuticals Inc.Dividend Hike & Growth Oriented Trading Recommendations - newser.com
Is Sonoma Pharmaceuticals Inc. stock in correction or buying zone2025 Historical Comparison & AI Enhanced Trading Signals - newser.com
Published on: 2025-11-19 00:56:45 - newser.com
How analysts revise price targets for Sonoma Pharmaceuticals Inc. (O8Z) stock2025 Technical Overview & Verified Trade Idea Suggestions - newser.com
Predicting Sonoma Pharmaceuticals Inc. trend using moving averages2025 Market WrapUp & Safe Capital Growth Tips - newser.com
Is Sonoma Pharmaceuticals Inc. stock gaining market share2025 Price Momentum & Fast Momentum Entry Tips - newser.com
Published on: 2025-11-16 04:08:08 - newser.com
Intraday pattern recognizer results for Sonoma Pharmaceuticals Inc.Earnings Growth Report & Stepwise Swing Trade Plans - newser.com
Why Sonoma Pharmaceuticals Inc. stock is favored by top institutionsForecast Cut & Safe Capital Allocation Plans - newser.com
Sonoma Pharmaceuticals Inc Stock (SNOA) Financials Data
Revenue
Net Income
Cash Flow
EPS
6.17%
0.67%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):